Handelsavisen
prelaunch
Companies Healthcare KPJH.KL
KP
KPJH.KL Bursa Malaysia Healthcare Facilities & Services

KPJ Healthcare Bhd

$3,15
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,33 %
Op margin
16,2 %
ROE
13,3 %
Net margin
8,6 %
Debt / equity
1,44
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

KPJ Healthcare Bhd operates in the healthcare facilities and services sector, providing medical services and pharmaceuticals to patients in Malaysia and potentially other markets.

Business. KPJ Healthcare Bhd (KPJH.KL) is a healthcare services company primarily engaged in the operation of healthcare facilities. The firm is headquartered in Malaysia and is listed on the Bursa Malaysia stock exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data. Consequently, the company is described at the industry level within the Healthcare Facilities & Services sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
BUY16 analysts
12 buy4 hold0 sell
Avg 12m price target3,32

Analyst recommendations

16 analysts · consensus Buy
Buy12
Hold4
Sell0
12-month price target
3,32
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
16 analysts · indicative
Ownership
not yet wired
Profitability
13,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning KPJH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to KPJH.KL. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    KPJ Healthcare Bhd (KPJH.KL) is a healthcare services company primarily engaged in the operation of healthcare facilities. The firm is headquartered in Malaysia and is listed on the Bursa Malaysia stock exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data. Consequently, the company is described at the industry level within the Healthcare Facilities & Services sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    KPJ Healthcare Bhd maintains a debt-to-equity ratio of 1.44, indicating a moderate reliance on debt financing, and a current ratio of 1.52, suggesting adequate short-term liquidity to cover its obligations. The company's free cash flow of MYR 250.39 million reflects its ability to generate cash after capital expenditures, although the capital expenditure of MYR -277.35 million indicates ongoing investment in infrastructure.

    The company's profitability is reflected in a return on equity (ROE) of 13.27% and a return on assets (ROA) of 4.55%, which are key metrics for evaluating the efficiency of equity and asset utilization. These figures suggest that KPJ Healthcare Bhd is generating a solid return for its shareholders, although the ROA is relatively modest compared to the ROE, indicating that the company is leveraging debt to enhance returns.

    KPJ Healthcare Bhd's revenue is primarily concentrated in Malaysia, with no disclosed breakdown of geographic or segmental revenue distribution in the provided data. This lack of diversification may expose the company to regional economic and regulatory risks, although the absence of detailed segmental data limits a more granular assessment.

    The company's growth trajectory is supported by a positive operating cash flow of MYR 893.40 million and a net income of MYR 365.93 million, indicating a stable financial position. Analysts have provided a mean price target of MYR 3.32, with a median of MYR 3.25, suggesting a generally positive outlook for the stock.

    KPJ Healthcare Bhd faces a medium liquidity risk and a low dilution risk, with no significant dilution sources identified in the provided data. The company's risk assessment highlights a key flag of negative net cash after subtracting total debt, which may impact its financial flexibility.

    Recent events and filings have not been disclosed in the provided data, limiting the ability to assess any recent strategic or operational developments. However, the company's financial performance and analyst sentiment suggest a stable and potentially growing business.

    Key takeaways
    • KPJ Healthcare Bhd maintains a strong ROE of 13.27%, indicating efficient use of equity capital.
    • The company's debt-to-equity ratio of 1.44 suggests a moderate level of leverage.
    • Analysts have a generally positive outlook, with a mean price target of MYR 3.32.
    • The company's liquidity position is adequate, with a current ratio of 1.52.
    • KPJ Healthcare Bhd's revenue concentration in Malaysia may expose it to regional risks.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $3,15
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $2.76B
    Net cash
    -$3.96B
    Current ratio
    1.5
    Debt / equity
    1.4
    ROA
    4.5%
    ROE
    13.3%
    Cash conversion
    244.0%
    CapEx / revenue
    -6.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,09
    Predicted surprise
    -0,00
    Beat probability
    45 %
    Analysts
    16
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-22 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,09
    Revenueno estimateno estimate4,5B MYR
    Operating incomeno estimateno estimate756,8M MYR
    Full-year consensus mean (period as reported by source) · consensus in MYR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution16 analysts
    Strong buy4
    Buy8
    Hold4
    Sell0
    Strong sell0
    12-month price target$3,32 · Median $3,25
    Low $2,80High $4,15
    Operating income · consensus756,8M MYR
    EPS surprise
    −9,4 %
    reported vs consensus · miss
    Revenue surprise
    −6,3 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$2,80
    Mean$3,32
    Median$3,25
    High$4,15
    Spot$3,15
    +5.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin16,2 %Above P75
    Net Margin8,6 %Above median
    ROE13,3 %Above P75
    Capex / Rev-6,5 %Above median
    D/E1,44Bottom quartile
    Cash Conv2,44Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • KPJ Healthcare Bhd Market data — financials · 2026-05-28
    • KPJ Healthcare Bhd Market data — analyst estimates · 2026-05-28
    • KPJ Healthcare Bhd Market data — ESG · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    KPJH.KLCanonical
    Bursa Malaysia · USD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage